Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:awards |
gptkb:Medilink_UK_Healthcare_Business_Award
|
| gptkbp:CEO |
gptkb:Richard_Kirk
|
| gptkbp:collaboratesWith |
NHS
|
| gptkbp:country |
gptkb:United_Kingdom
|
| gptkbp:focusesOn |
non-invasive treatments
|
| gptkbp:foundedIn |
2009
|
| gptkbp:founder |
gptkb:Richard_Kirk
|
| gptkbp:headquartersLocation |
gptkb:Sedgefield,_United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
PolyPhotonix
|
| gptkbp:industry |
gptkb:biotechnology
medical devices |
| gptkbp:Noctura_400 |
medical device for diabetic retinopathy
|
| gptkbp:product |
gptkb:Noctura_400
|
| gptkbp:specializesIn |
ophthalmology
light therapy |
| gptkbp:technology |
gptkb:organic_light-emitting_diode_(OLED)
|
| gptkbp:website |
https://www.polyphotonix.com/
|
| gptkbp:bfsParent |
gptkb:NETPark
|
| gptkbp:bfsLayer |
7
|